1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Respiratory conditions
  5. Asthma

Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over

Technology appraisal guidance [TA138] Published: 26 March 2008

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Related NICE guidance
  • 7 Review of guidance
  • Appendix A: Appraisal Committee members and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Appendix C: Products included in appraisal
  • Changes after publication
  • About this guidance
Download guidance (PDF)

Guidance

  • Next

6 Related NICE guidance

6 Related NICE guidance

  • Omalizumab for severe persistent allergic asthma. NICE technology appraisal guidance 133 (2007).

  • Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years. NICE technology appraisal guidance 131 (2007).

  • Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years). NICE technology appraisal guidance 38 (2002).

  • Inhaler systems (devices) in children under the age of 5 years with chronic asthma. NICE technology appraisal guidance 10 (2000).


  • Next